Podcast

Heard at NAACOS: Focus on Proposed MSSP Changes

CMS’ accountable care organization program, the Medicare Shared Savings Program (MSSP), could potentially be undergoing some big changes. During the recent fall 2018 meeting of the National Association of ACOs (NAACOS), the proposed changes were top of mind. Attendees were most concerned about how the faster timeline to taking on risk would impact participation, but were pleased with changes to the benchmark and risk adjustment.

CMS’ accountable care organization (ACO) program, the Medicare Shared Savings Program, could potentially be undergoing some big changes. During the recent fall 2018 meeting of the National Association of ACOs, the proposed changes were top of mind. Attendees were most concerned about how the faster timeline to taking on risk would impact participation, but were pleased with changes to the benchmark and risk adjustment.

In this episode of Managed Care Cast, stakeholders at ACOs and policy experts discuss the proposed changes and their potential impact on ACO participation.

Log in to listen to the podcast.

iTunes: http://apple.co/2eYWTss

TuneIn: http://bit.ly/2gv7iwj

Stitcher: http://bit.ly/2gCqtFg

Listen above or through one of these podcast services:

CMS Plans to Overhaul MSSP Program to Force More Risk on ACOs

Proposed Rule for Medicare ACOs Includes Notable Changes for Rural Providers

CMS Proposal Is a Start for Making Risk More Appealing to ACOs

MSSP Proposal Better Measures Risk With Changes to the Benchmark Methodology

MSSP Changes Present Opportunities, but Likely to Decrease Number of ACOs, NAACOS Says

Physician ACOs Associated With Growing MSSP Savings Over 3 Years

Read more about the stories in this podcast:

Related Videos
dr carol regueiro
dr carol regueiro
dr carol regueiro
Screenshot of an interview with Stuart Staggs
Screenshot of an interview with James Chambers, PhD
Corey McEwen, PharmD, MS
dr linda bosserman
dr andrew leitner
dr joseph alvarnas
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo